quinacrine has been researched along with isoniazid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Illei, G; Morgan, DM | 1 |
| Flint, SF; Gregory, FJ; Healy, EM; Warren, GH | 1 |
| Smith, B | 1 |
| Greengard, P; Quinn, GP; Reid, MB | 1 |
| Stoliarov, GV | 1 |
| Eady, RR; Large, PJ | 1 |
| Holmes, J; Sapeika, N; Zwarenstein, H | 1 |
| Solov'ev, VN; Zueva, VS | 1 |
| Bradley, SG; Hall, WH; Manion, RE | 1 |
| Berman, JD; Lee, LS | 1 |
| Geromichalos, GD; Harkitis, P; Karamanakos, PN; Konstandi, M; Marselos, M; Pappas, P; Trafalis, DT | 1 |
16 other study(ies) available for quinacrine and isoniazid
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Polyamine oxidase activity in human pregnancy serum.
Topics: Cross-Sectional Studies; Female; Humans; Isoniazid; Male; Oxidoreductases Acting on CH-NH Group Donors; Pregnancy; Quinacrine; Spermine | 1979 |
Effect of mixtures of atabrine and antibacterial agents on the emergence of resistant strains of Mycobacterium tuberculosis.
Topics: Aminosalicylic Acids; Dihydrostreptomycin Sulfate; Drug Resistance, Microbial; Isoniazid; Mycobacterium tuberculosis; Quinacrine | 1967 |
The myenteric plexus in drug-induced neuropathy.
Topics: Animals; Ganglia, Autonomic; Injections, Intraperitoneal; Injections, Intravenous; Intestine, Large; Isoniazid; Mice; Microscopy, Fluorescence; Myenteric Plexus; Peripheral Nervous System Diseases; Quinacrine; Staining and Labeling; Vinblastine | 1967 |
Prevention by antidepressant drugs of reserpine effect on pyridine nucleotide metabolism.
Topics: Aminopyrine; Amitriptyline; Amphetamine; Animals; Antidepressive Agents; Atropine; Benactyzine; Caffeine; Chlorpheniramine; Chlorpromazine; Female; Hexobarbital; Hydralazine; Hypothalamus; Imipramine; Iproniazid; Isoniazid; Liver; Meprobamate; Methacholine Compounds; Morphine; NAD; Niacinamide; Pargyline; Pentobarbital; Phenylbutazone; Phenytoin; Quinacrine; Rats; Reserpine; Tranylcypromine; Tripelennamine; Zoxazolamine | 1966 |
[On the course of drug psychoses].
Topics: Adrenocorticotropic Hormone; Adult; Atropine; Barbiturates; Chlorpromazine; Disulfiram; Drug Hypersensitivity; Female; Humans; Isoniazid; Male; Prednisolone; Psychoses, Substance-Induced; Quinacrine; Time Factors | 1968 |
Purification and properties of an amine dehydrogenase from Pseudomonas AM1 and its role in growth on methylamine.
Topics: Amines; Amino Alcohols; Chloromercuribenzoates; Chromatography, Gel; Coloring Agents; Cytochromes; Electron Transport; Ferricyanides; Flavins; Histamine; Hydrogen-Ion Concentration; Isoniazid; Kinetics; NAD; NADP; Oxidoreductases; Oxygen; Phenazines; Pseudomonas; Quinacrine; Semicarbazides; Spectrophotometry; Succinates; Temperature; Vitamin K | 1968 |
Inhibitory effect of some quinoline, phthalazine, and coumarin derivatives on glucose-6-phosphate dehydrogenase in vitro.
Topics: Binding, Competitive; Chloroquine; Coumarins; Glucosephosphate Dehydrogenase; Heterocyclic Compounds; Hydralazine; Isoniazid; Novobiocin; Phenazines; Phenelzine; Phenylhydrazines; Probenecid; Pyridines; Quinacrine; Quinidine; Quinine; Quinolines; Sulfanilamides; Warfarin; Yeasts | 1973 |
[Effect of acridine compounds on the development of drug resistance to antitubercular agents of Mycobacterium of avian type].
Topics: Acridines; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Quinacrine; Streptomycin; Tuberculosis | 1969 |
Retardation of the emergence of isoniazid-resistant mycobacteria by phenothiazines and quinacrine.
Topics: Aminosalicylic Acids; Dibenzazepines; Drug Resistance, Microbial; Drug Synergism; Isoniazid; Methods; Mycobacterium; Phenothiazines; Quinacrine; Spectrophotometry | 1969 |
Activity of oral drugs against Leishmania tropica in human macrophages in vitro.
Topics: Antiprotozoal Agents; Cells, Cultured; Drug Interactions; Humans; Isoniazid; Ketoconazole; Leishmania; Macrophages; Metronidazole; Nitrofurans; Phenothiazines; Quinacrine; Rifampin; Sulfamethoxazole; Trimethoprim | 1983 |
Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity.
Topics: Adult; Animals; Antimutagenic Agents; Binding Sites; Blotting, Western; Cytochrome P-450 CYP2E1 Inhibitors; Disulfiram; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Humans; Isoniazid; Male; Models, Molecular; Mutagens; Nitrosamines; Protein Binding; Quinacrine; Rats; Rats, Wistar; Sister Chromatid Exchange | 2009 |